Summary Two-dimensional 
The range of histological appearances of primary lung cancer is extremely wide, even although most of such tumours originate in bronchial epithelium. From a therapeutic standpoint, lung cancer is usually classified into small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). Small-cell lung cancers which contain cytoplasmic dense-core granules resembling neuroendocrine granules, seem to originate from Kultschitzky cells. SCLC is characteristic of both neuroendocrine cells and epithelial cells, and the biological behaviour of SCLC is different from that of NSCLC.
NSCLC can be subdivided into squamous cell carcinoma (SCC), adenocarcinoma (AdC) and large-cell carcinoma (LCC) . SCC derives from basal cells or intermediate cells of the relatively large bronchi, and is generally preceded by squamous metaplasia with increasing degree of atypia Nasiell et al., 1982; Hirano et al., 1994 Recently, several multistep models of epithelial carcinogenesis have been postulated. These models suggest that abnormalities in several kinds of oncogenes and tumoursuppressor genes play an important part in carcinogenesis (Fearon and Vogelstein, 1990) . In this context we believe that the investigation of the molecular events which occur during malignant transformation in bronchial epithelial cells may be the basis for the development of improved diagnostic methods and treatment modalities of PLC. We also suggest that analysis of gene products contributes valuable information concerning tumour aggressiveness and treatment sensitivity, since most cellular functions are related to proteins.
We recently reported that two-dimensional polyacrylamide gel electrophoresis (O'Farrell, 1975) combined with a non-enzymatic sample preparation technique is useful for analysing clinical tumour material (Okuzawa et al., 1994; Franzen et al., 1993) . A number of polypeptides were overexpressed in SCLC compared with NSCLC. However, only a few polypeptides seem to differ among various types within the NSCLC group. The molecular weight region in our previous study was focused to 30-150 kDa by the homogeneous 10%T second dimension. Other investigators suggest that new potential markers may occur in the molecular weight region 10-20 kDa (e.g. Op18/stathmin and nm23) (Strahler et al., 1992; Rosengard et al., 1989) . Therefore, we extended the molecular weight range using a 10-13%T linear gradient. We (Figure 1 ). The cell suspension was filtered and centrifuged at 1000g for 3 min. After resuspension of the cells, 54.7% Percoll solution (density = 1.07) was carefully underlaid, and centrifuged at 1000g for 15min. The interphase cell layer was collected, and the cells were washed in phosphate-buffered saline (PBS). After recording the wet weight of the final cell pellet, the materials were frozen and stored at -80°C.
During final preparation of the samples, cells were broken by repeated freezing and thawing, and nucleic acids were degraded using DNAse/RNAse. After lyophilisation, the material was solubilised using a sample buffer containing urea, dimethylammonio]-l-propanesulphonate (Chaps). After extensive mixing, any remaining insoluble material was removed by centrifugation.
Finally, the protein concentration of the sample was determined (Bradford, 1976) , and samples were stored at -80°C prior to isoelectric focusing (IEF).
Two-dimensional polyacrylamide gel electrophoresis 2-DE was performed according to previous descriptions (Franzen et al., 1993; Okuzawa et al., 1994 Figure 1 Schematic illustration showing the main steps in the preparation procedure. The fresh surface of a resected tumour is scraped with a scalpel. The cell-rich material that attaches to the scalpel is transferred to ice-cold cell culture medium containing 5% fetal calf serum and protease inhibitors. In the same location where the tumour surface was scraped, a small piece of the tumour is harvested for fixation in 4% formalin for histological examination.
6.8) containing sodium dodecyl sulphate (SDS), dithiothreitol (DDT) and glycerol, frozen on dry ice immediately, and finally stored at -80°C.
A linear 10%-13%T gradient SDS-polyacrylamide gel (1.0 x 180 x 190 mm in size) was used in the second dimension. The IEF gels were sealed using agarose on top of the slab gels, and electrophoresed overnight using 10 mA per gel at + 10°C.
After protein fixation, proteins were visualised by silver staining (Morrissey, 1981) . 841 Identification of known polypeptides Identification of human polypeptides was possible through comparison of the 2-DE patterns obtained and previously published 2-DE maps (Bhattacharya et al., 1990; Ochs et al., 1981; Garrels and Franza, 1989; Celis et al., 1992) , or coelectrophoresis of purified polypeptides and subcellular fractions, as well as characterised samples from other laboratories.
Cellular extract of vimentin and vimentin-derived polypeptides, tropomyosins and cytokeratins from the cell lysate of cell lines MDA-231 (human breast cancer), MCF-7 (human breast cancer) and WI38 (human lung fibroblasts) were prepared for the identification of each group of spots (Gard et al., 1979; Paulin et al., 1980; Matsumura et al., 1983) . Proliferating cell nuclear antigen (PCNA) was identified by immunoblotting (PC10 monoclonal antibody against PCNA) using a semi-dry system (Multiphore, Pharmacia-LKB Biotechnology AB) and ECL detection (Amersham).
Results

Histopathologicalfindings
The histopathological diagnoses of all cases investigated are presented in Table I . In addition to the routine histopathological diagnosis, two pathologists re-evaluated all cases independently. In three cases of adenocarcinoma (L206, L223 and LTI0) the degree of differentiation was not determined because the histopathological specimen was too small to reflect the characteristics of the entire tumour. (Figure 3 ).
In the region marked in Figure 3 16 spots were tentatively judged as polypeptides associated with histopathological features. These spots were called TEOI, TE02, TE03 (these three spots were obviously detected in NSCLC samples), TSO1, TS02, TS03, TS04 (these four spots were detected in almost all samples of SCLC), TAO1, TA02, TA03, TA04, TA05 (these five spots were detected in almost all samples of AdC), TSqOl, TSqO2, TSqO3 and TSqO4 (these four spots were detected mainly in samples of SCC). The localisation of all these spots is shown in each gel (see Figure 5) , and the expression levels of these spots were classified as 'negative', 'low', 'intermediate' and 'high'.
The calculated molecular weight and isoelectric point of each polypeptide are shown in Table II . The isoelectric point was calculated using a number of internal markers (Bjellqvist et al., 1994) .
All spots, except some TSq polypeptides, were undetected in the human lung fibroblast cell line WI38. Also, normal peripheral lymphocytes did not express these polypeptides, with the exception of TE02, TSqO2, TAO1, TA02 and TA05, but their expression levels were very low ( Figure 3) .
Most of the breast cancers expressed TEOI, TE02, TA03 and TA05, but the other polypeptides were detected in few breast cancer samples (Table II, The intensity and rate of each TA polypeptide correspond to the degree of AdC differentiation (Figure 6 ). In particular, the expression level of TAOI and TA02 was related with the degree of AdC-differentiation.
Comparison of 2-DE patterns ofsquamous cell carcinoma and other histological types ofprimary lung cancer TSqOl, TSqO2, TSqO3 and TSqO4 polypeptides were expressed in more than 60% of SCC and AdSCC samples and in Squamous cell carcinoma (n = 10) TEO1   TE02  TE03  TSO1  TS02  TS03  TS04  TA01  TA02  TA03  TA04  TA05  TSqO1   TSqO2  TSqO3  TSqO4   20  40  60 80 100(%)
Adenosquamous cell carcinoma (n = 1) TEOI  TE02  TE03  TSO1  TS02  TS03  TS04   TAOI  TA02  TA03  TA04  TA05  TSqO1  TSqO2  TSqO3  TSqO4   20 40 60 80 100 (%)
Small-cell carcinoma (n = 5) TEOl  TE02  TE03   TSO1 r&111=11111A   TS02  TS03   TSO4   TAOI  TA02  TA03  TA04  TAOS   TSqO1   TSqO2  TSqO3  TSqO4 Large cell carcinoma (n = 5) TE01  TE02  TE03  TS01  TS02  TS03  TS04  TA01  TA02  TA03  TA04  TAOS  TSqOl  TSqO2  TSqO3  TSqO4 Carcinoid (n = 3) TE01  TE02  TE03  TS01  TSO2  TS03  TS04  TAO1  TA02  TA03  TA04  TA05  TSqOl  TSqO2  TSqO3  TSqO4   20   40  60  80 fewer than 20% of AdC samples. These four TSq polypeptides seem to be associated with SCC.
Discussion
Primary lung cancer (PLC) is one of the most malignant solid tumours, and lung cancer incidence and thus mortality is increasing. Clinically, lung cancer is divided into SCLC and NSCLC. This division guides the therapeutic strategy because of the large difference in the sensitivity to chemotherapy as well as radiotherapy, and in the frequency of distant metastasis. Usually, it is possible to distinguish between SCLC and NSCLC on the basis of morphology. However, recently it has been shown that cases borderline between SCLC and NSCLC exist, causing diagnostic difficulties. showed that at least 10% of NSCLC are accompanied by neuroendocrine features (NE) (e.g. Ldopa decarboxylase and chromogranin A) and that these tumours possess cytoplasmic granules resembling neuroendocrine granules. Also, NSCLC with NE is more sensitive to chemotherapy than typical NSCLC which do not show NE. However, it has been reported to be impossible to distinguish histologically between typical NSCLC and NSCLC with NE . Furthermore, it has been shown that a few cases of AdC of the lung express cluster 1 SCLC antigen (Tome et al., 1991) , which is present on every SCLC, as well as on neural, endocrine and muscle cells (Hirano et al., 1989) . At present, this antigen is considered to be synonymous with the neural cell adhesion molecule (N-CAM) (Patel et al., 1989 al., 1982; Nomori et al., 1986; Hirsh et al., 1988) .
All these findings show that borderline cases between SCLC and NSCLC exist, and it is very difficult to distinguish these cases from either typical SCLC or NSCLC based only on morphological findings. Therefore, it is valuable to analyse the gene expression of PLC, and we consider that the analysis of polypeptides associated with PLC, using 2-DE, may reflect the biological characteristics of the tumour more accurately.
Potential markers for epithelial cells
TEOl and TE02 were strongly expressed in all NSCLC.
However, these two polypeptides were not detected in all cases of oat cell carcinoma (L11O case), while intermediate cell type SCLC expressed low levels compared with NSCLC. These polypeptides were also detected in all breast cancer samples analysed (Table III We believe that these three TE polypeptides may be valuable not only to distinguish between SCLC and NSCLC, but also to guide the therapeutic strategy of SCLC by evaluating the epithelial characteristics of SCLC. This is because an increase in the epithelial characteristics may result in a lower sensitivity to chemotherapy.
Potential markers for neuroendocrine cells
The findings concerning the histological distribution of TSO1, TS02, TS03 and TS04 suggest that these four polypeptides originate from neuroendocrine cells. Expression of these four polypeptides in oat cell type SCLC (L110) supports the concept that these polypeptides may reflect neuroendocrine features (NE). Even in intermediate cell type SCLC and carcinoid tumours in which low levels of TEOl and TE02 are detected, more than two polypeptides out of these four TS polypeptides are expressed.
Neuron cytoplasmic protein has a molecular weight of 26.3 kDa and pl 5.44 (Celis et al., 1992) , and may correspond to either TS02 or TS03.
Although no NSCLC samples expressed more than two kinds of TS polypeptides, samples LOlT (PD AdC), L121, LT32 (LCC) and L107 (AdSCC) expressed one of these TS polypeptides. These four cases showed positive staining of neuron-specific enolase, and in one of these four cases chromogranin A was detected. Furthermore, the tumour with chromogranin A positive staining possessed cytoplasmic granules resembling neuroendocrine granules (data not shown). These findings suggested that some of the four tumours that expressed one TS polypeptide might be NSCLC with NE, and that TS polypeptides might be associated with NE. However, in order to confirm the relationship between these four polypeptides and NE, more data are necessary. (Table III) . Furthermore, three cases of metastatic lung carcinoma from the colon and rectum did not express these two polypeptides (data not shown). These findings suggest that these two polypeptides may have some specificity for AdC of the lung. Antibodies against TAOI and TA02 are needed to investigate the detailed cellular distribution of these polypeptides.
The expression of TA04 was low in AdC cases, but it was hardly ever detected in SCLC, SCC, breast cancer or metastatic lung cancer from the colon and rectum. In addition to TAOI and TA02, TA04 may be useful to distinguish between primary AdC and metastatic AdC from other organs.
In comparison with the findings for TAOI, TA02 and TA04, the range of distribution of TA03 and TA05 was rather wide, because most breast cancers expressed TA03 and TA05. It is highly possible that TA03 and TA05 may be common polypeptides in adenocarcinomas.
Potential markers for squamous cell lung carcinoma It is difficult to define the polypeptides associated with SCC. Necrotic tissue is often observed in SCC, and bacterial infection is sometimes present. Therefore, it is very difficult to analyse SCC. In this study candidates for SCC-associated polypeptides are described. However, although AdC, SCLC and carcinoid tumours expressed some of these polypeptides, the number and level of expression of SCC-associated polypeptides are low.
Analysis of adenosquamous cell carcinoma and large-cell carcinoma The AdSCC sample (L107) expressed all polypeptides associated with both AdC and SCC as well as three TE polypeptides. The level of expression of TE polypeptides was high or intermediate, but the other polypeptides associated with AdC and SCC were expressed relatively weakly. These findings in AdSCC seem to be reasonable, because each polypeptide may be diluted by the polypeptides associated with other histological entities.
Similar findings were observed in the 2-DE pattern of four out of five LCC cases. We believe that LCC cells have a weak potential to differentiate to both AdC and SCC, which is subsequently reflected by the mixed type of the 2-DE pattern. The fact that the 2-DE pattern of PD AdC shows low levels of TA polypeptides and little expression of TSq polypeptides supports this hypothesis ( Figure 6 ).
We have previously identified several kinds of polypeptides associated with high proliferation (e.g. PCNA, PCNA 'satellite', numatin/protein B23 and lamin B). We also reported that the high levels of PCNA, B23 and lamin B, and the expression of PCNA 'satellite' may indicate rapidly growing tumours (Okuzawa et al., 1994) . These polypeptides were frequently detected in SCLC. In this study in which we analysed polypeptides mainly in the molecular weight region 20-35 kDa of 2-DE gel, we could not establish any definite difference between SCLC and carcinoid tumours. However, by comparing the polypeptides associated with high proliferation it is possible to distinguish SCLC from carcinoid tumours in 2-DE findings. It is valuable to analyse several kinds of differentiation markers and proliferation markers simultaneously. We believe that the combination of 2-DE and the non-enzymatic sample preparation technique enables the simultaneous evaluation of these markers in clinical material.
We observed that the major fraction of resolved polypeptides varies significantly among the cases. However, small differences in 2-DE patterns between parallel samples from the same tumour were detected, because clinical samples always show tumour heterogeneity and contamination by non-tumour cells (e.g. fibroblasts, lymphocytes and granulocytes) (Franzen et al., 1993) . In the present study it is important to compare the results of the clinical samples with the 2-DE pattern from fibroblasts and lymphocytes. Even though fibroblasts or lymphocytes expressed some of these polypeptides, the level of expression of most of the polypeptides was much lower than the level found in cancerous samples. No relationship between the intensity of the histology-associated polypeptides and the number of mesenchymal cells and lymphocytes was observed in this study.
The ultimate aim of this study was to characterise the various histologically defined tumours by means of specific 2-DE patterns. It is reasonable to assume that there are relationships betwen biological characteristics, sensitivity to several kinds of therapy and prognosis. For that purpose, investigation of the relationship between the polypeptides associated with the histopathological differentiation of PLC and both neuroendocrine characteristics and epithelial characteristics may be an effective strategy.
Abbreviations PCNA, proliferating cell nuclear antigen; PLC, primary lung carcinoma; SCLC, small-cell lung carcinoma; NSCLC, non-small-cell lung carcinoma; SCC, squamous cell lung carcinoma; AdC, lung adenocarcinoma; AdSCC, adenosquamous cell lung carcinoma; LCC, large-cell lung carcinoma; WD AdC, well-differentiated AdC; MD AdC, moderately differentiated AdC; PD AdC, poorly differentiated AdC; IEF, isoelectric focusing; PMSF, phenylmethylsulphonyl fluoride; SDS, sodium dodecyl sulphate; NE, neuroendocrine feature.
